LBLili Bai

Lili Bai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lili Bai has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Dongyong Zhang

    Department of Neurosurgery, The First Hospital of China Medical University, China Medical University, Shenyang City, China

    1 shared publication
  • Fu Ren

    Shenyang Medical College, Shenyang, Liaoning 110034, PR China; Liaoning Province Key Laboratory for Phenomics of Human Ethnic Specificity and Critical Illness (LPKL-PHESCI), Shenyang, Liaoning 110034, PR China; Shenyang Key Laboratory for Phenomics, Shenyang, Liaoning 110034, PR China

    1 shared publication
  • Tianchi Zhang

    Department of Computer and information technology, University of Pennsylvania, Philadelphia, PA 15419, USA

    1 shared publication
  • Yiwei Wang

    Shenyang Medical College

    1 shared publication
  • Zhongyan Li

    Department of Critical Care Medicine, Fuxin Central Hospital, Fuxin 123000, China

    1 shared publication

Latest Publications

  • Open Access

    Scinderin Is a Novel Oncogene for Its Correlates with Poor Prognosis, Immune Infiltrates and Matrix Metalloproteinase-2/9 (MMP2/9) in Glioma

    by Yiwei Wang, Zhongyan Li, Lili Bai, Dongyong Zhang, Tianchi Zhang, Fu Ren

    Purpose: The effect of scinderin (SCIN) on cancer progression has been studied, but its role in glioma remains unknown. This study describes the value of SCIN for the diagnosis, prognosis, and treatment of glioma. Methods: The expression of SCIN was analyzed using the GEPIA, Oncomine, cBioPortal, and CGGA databases. GO/KEGG enrichment analysis of similar genes to SCIN were performed using the R software package, and the protein–protein interaction (PPI) network was analyzed by the STRING and GeneMANIA databases. The correlations of mRNA expression between SCIN and MMP2/9 were analyzed by TCGA glioma. Simultaneously, the TISIDB and TIMER databases were used to analyze the correlation between SCIN and immune infiltration. Finally, SCIN and MMP2/9 protein expression among different grades of glioma was performed and the results were obtained via immunohistochemistry and Western blot assays. We used the Kaplan–Meier method and Cox proportional hazards model to assess the impact of SCIN and MMP2/9 on glioma patients’ survival. The correlations between SCIN and MMP2/9 were analyzed by immunohistochemistry and Western blot assays. Results: SCIN was upregulated in glioma patients with a poor prognosis. The GO and KEGG enrichment analysis showed the functional relationship between SCIN and the immune cell activation and regulation. In addition, the expression of SCIN was related to MMP2/9 in glioma. The correlation analysis showed that SCIN expression was associated with tumor purity and immune infiltration. SCIN and MMP2/9 are negative prognostic factors resulting in worsening glioma patients’ survival. Conclusion: Our studies demonstrated that SCIN expression was associated with MMP2/9, immune infiltration, and a poor prognosis in glioma. SCIN may serve as a potential prognostic marker and an immune therapy target for glioma.